Journal of Child Neurology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chez, M. G.
Right arrow Articles by Bagan, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chez, M. G.
Right arrow Articles by Bagan, B. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Child Neurology, Vol. 14, No. 4, 239-242 (1999)
DOI: 10.1177/088307389901400405

Clinical Experience of Three Pediatric and One Adult Case of Spike-and-Wave Status Epilepticus Treated With Injectable Valproic Acid

Michael G. Chez, MD

Pediatric Epilepsy Program, Lake Forest Hospital Lake Forest, IL

Michael S. Hammer, MD

Pediatric Epilepsy Program, Lake Forest Hospital Lake Forest, IL, Department of Pediatrics, Lutheran General Hospital, Park Ridge, IL

Maurice Loeffel, BA

Caralynn Nowinski

Bradley T. Bagan, MS

Subclinical or nonconvulsive status epilepticus may cause severe postmorbid neurologic dysfunction. It is, therefore, critical to rapidly identify and treat these cases. The recent availability of injectable valproic acid (Depacon) provides an additional method for treatment of status epilepticus, although studies concerning its effectiveness are not widely available in the literature. We report four cases (three pediatric, one adult) of patients who presented to us in status epilepticus. All had previously failed more than one other common method of treatment for this condition. Treatment with injectable valproic acid resulted in the elimination of all clinical indications of status epilepticus as well as a return to the baseline EEG condition in all four cases. Seizure types included focal, multifocal, and generalized spike and wave forms, suggesting potential benefit from injectable valproic acid treatment in a wide range of status epilepticus patients. We present these cases for review. (J Child Neurol 1999; 14:239-242).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
W. G. Mitchell
Status Epilepticus and Acute Serial Seizures in Children
J Child Neurol, January 1, 2002; 17(1_suppl): S36 - S43.
[Abstract] [PDF]

Home page
 NeurologyHome page
R. D. Sheth and B. E. Gidal
Intravenous valproic acid for myoclonic status epilepticus
Neurology, March 14, 2000; 54(5): 1201 - 1201.
[Full Text] [PDF]